In News

In News

Lupin: The USFDA has issued Form-483 with 8 observations for the drug product facility and API facility at Mandideep. The US drug regulator has inspected company's Mandideep unit-1 facility during November 14-23, 2022. "We do not believe this will have an impact on disruption of supplies or the existing revenues from operations of this facility," the company said.

Hariom Pipe Industries: The company has completed the setting up of its 15 ton electric melting furnace and the commercial production from the same will commence from November 25, 2022. This will increase the company's production of MS billets from the current 95,832 MTPA to 1.04 lakh MTPA.

Punjab National Bank: The public sector lender has received approval of DIPAM, Ministry of Finance, for divestment of stake in UTI Asset Management Company in single or multiple tranches. As of now, PNB holds 15.22 percent stake in UTI AMC. The objective is to realise gain on investment.

Tube Investments of India: The auto ancillary company will pick 50 percent stake in X2Fuels and Energy, a start-up company engaged in developing processes to convert waste to liquid/solid fuels, for Rs 6.15 crore. Tube Investments has signed shares' subscription agreement with X2Fuels and Energy, and its founders.

Laurus Labs: The company has entered into Share Subscription Agreement and Shareholders' Agreement with Ethan Energy India for buying 26 percent stake in Ethan Energy India. This will enable the company to consume 100 percent of the solar energy to be supplied by Ethan Energy India from their 10 MW solar energy plant.

Kintech Renewables: Promoters Gaurank Singhal & Aditya Singhal will sell 1.96 lakh shares or 19.69 percent stake via offer for sale on November 25 and November 28. The floor price for the sale would be Rs 480 per share.

Biocon: Biocon Biologics has allotted equity shares worth Rs 2,205.63 crore to parent company Biocon. Its stake in Biocon Biologics will be 88.85% post allotment of shares.